Lung Cancer Genetics Study: New Hope Through Genetic Research
Learn how the Lung Cancer Genetics Study is collecting patient genetic and clinical data to accelerate discoveries, support personalized treatment, and bring new hope to families facing lung cancer.
A powerful new genetics study is offering fresh hope in the fight against lung cancer — especially for patients with rare mutations and those who’ve never smoked. The Lung Cancer Genetics Study, launched in 2024 by 23andMe and supported by nearly two dozen patient advocacy groups, is collecting genetic and clinical data from thousands of lung cancer patients to help uncover what drives this complex disease. It’s one of the first efforts of its kind to truly center patient voices from the beginning, ensuring that research reflects real-world experiences.
The project began with a friendship between two women living with lung cancer, Ilana Stromberg and Susan Troper Wojcicki, both mothers of five and determined to make a difference. Motivated by the lack of research and funding for lung cancer, especially RET-positive and other biomarker-driven subtypes, they envisioned a national lung cancer registry that could drive discoveries and lead to better, more personalized treatments. Susan’s passing in 2024 makes the study even more meaningful to those involved. Her legacy lives on through this groundbreaking initiative, which is expected to accelerate research and give families facing lung cancer a renewed sense of hope. (Source: 23andMe Blog)
Read the complete article here >
You’re Not Alone—Connect with the Stage 4 Hope Community
Whether you’re navigating treatment options, seeking emotional support, or trying to make sense of a new diagnosis, Stage 4 Hope is here for you. Learn more about topics like lung cancer genetics study by joining our community. Connect with others who understand your experience and gain access to trusted resources, upcoming events, medical updates, and invitations to supportive virtual gatherings.
